Abstract
In December 2023 an Endocrine Health Day expert workshop was held that involved more than 50 experts in gynecological endocrinology and menopausal hormone therapy from all regions of Russia. During the expert meeting, the issues related to management of women at their late repro-ductive and postreproductive (menopause) stages most important for clinicians were discussed. The leading experts discussed the upward trends of car-diovascular risk factors in the female population, the role of progesterone at the late reproductive stage and during perimenopause, treatment options for menstrual disorders during this period. The workshop was focused mainly on menopausal hormone therapy (MHT) selection and principles of MHT prescription to patients with premature ovarian failure and peri- and postmenopausal patients with comorbidities, management options for thrombosis risk in terms of evidence-based medicine, features of MHT selection in patients with metabolic disorders.
Keywords: late reproductive stage, perimenopause, menopausal hormone therapy, cardiovascular risk, metabolic disorders.
Keywords: late reproductive stage, perimenopause, menopausal hormone therapy, cardiovascular risk, metabolic disorders.
For citation:Expert council safeguarding female endocrine health. Clinical review for general practice. 2023; 4 (9): 85–92 (In Russ.). DOI: 10.47407/kr2023.4.9.00314
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
